Publicaciones (54) Publicaciones de MARÍA JOSÉ CATALÁN ALONSO

2023

  1. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  2. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124

2022

  1. Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial

    Brain Stimulation

  2. Long-term directional deep brain stimulation: Monopolar review vs. local field potential guided programming

    Brain Stimulation, Vol. 15, Núm. 3, pp. 727-736

2021

  1. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease

    BMC Neurology, Vol. 21, Núm. 1

  2. Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  3. Predictors of clinically significant quality of life impairment in Parkinson’s disease

    npj Parkinson's Disease, Vol. 7, Núm. 1

  4. Predictors of global non-motor symptoms burden progression in parkinson’s disease. Results from the coppadis cohort at 2-year follow-up

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  5. Staging Parkinson’s disease combining motor and nonmotor symptoms correlates with disability and quality of life

    Parkinson's Disease, Vol. 2021

2020

  1. Effects of Motor Symptom Laterality on Clinical Manifestations and Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1611-1620

  2. Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort

    Scientific Reports, Vol. 10, Núm. 1

  3. Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression

    Journal of the Neurological Sciences, Vol. 418

2019

  1. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson’s disease patients

    Journal of Neural Transmission, Vol. 126, Núm. 12, pp. 1599-1608

  2. Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions

    Molecular Oncology, Vol. 13, Núm. 12, pp. 2633-2645

  3. Psychometric properties of the apathy scale in advanced Parkinson's disease

    Parkinson's Disease, Vol. 2019

2018

  1. Cost-utility analysis of two formulations of botulinum toxin type a in the treatment of blepharospasm and cervical dystonia in Spain

    Revista de Neurologia, Vol. 67, Núm. 12, pp. 465-472

  2. Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease

    Journal of Neurology, Vol. 265, Núm. 6, pp. 1279-1287

2017

  1. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features

    Movement Disorders

2016

  1. Liquid biopsy in non-small cell lung cancer

    Frontiers in Medicine

2014

  1. Alteraciones genéticas más comunes asociadas a la enfermedad de Parkinson

    Revista española de trastornos del movimiento, Vol. 6, Núm. 2, pp. 10-17